XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders' Equity Attributable to Acushnet Holdings Corp.
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Tax
Retained Earnings
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2022     76,322          
Beginning balance at Dec. 31, 2022 $ 976,703 $ 939,056 $ 76 $ 960,685 $ (109,668) $ 473,130 $ (385,167) $ 37,647
Changes in stockholders' equity                
Sale of equity to redeemable noncontrolling interest 264 264   444   (180)    
Net income (loss) 225,870 225,237       225,237   633
Other comprehensive loss (income) (13,102) (13,102)     (13,102)      
Share-based compensation 20,877 20,877   20,877        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     484          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (11,359) (11,359) $ 1 (11,360)        
Purchases of common stock (Note 10) (112,448) (112,448)         (112,448)  
Share repurchase liability (Note 10) (79,765) (79,765)         (79,765)  
Dividends and dividend equivalents declared (40,394) (40,394)       (40,394)    
Ending balance (in shares) at Sep. 30, 2023     76,806          
Ending balance at Sep. 30, 2023 966,646 928,366 $ 77 970,646 (122,770) 657,793 (577,380) 38,280
Beginning balance (in shares) at Dec. 31, 2022     76,322          
Beginning balance at Dec. 31, 2022 976,703 939,056 $ 76 960,685 (109,668) 473,130 (385,167) 37,647
Changes in stockholders' equity                
Dividends and dividend equivalents declared (53,335)              
Ending balance (in shares) at Dec. 31, 2023     63,429          
Ending balance at Dec. 31, 2023 903,087 864,235 $ 63 808,615 (104,349) 159,906 0 38,852
Beginning balance (in shares) at Jun. 30, 2023     76,782          
Beginning balance at Jun. 30, 2023 1,055,217 1,017,219 $ 77 965,446 (114,345) 613,584 (447,543) 37,998
Changes in stockholders' equity                
Net income (loss) 57,589 57,307       57,307   282
Other comprehensive loss (income) (8,425) (8,425)     (8,425)      
Share-based compensation 5,141 5,141   5,141        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     24          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) 59 59   59        
Purchases of common stock (Note 10) (64,918) (64,918)         (64,918)  
Share repurchase liability (Note 10) (64,919) (64,919)         (64,919)  
Dividends and dividend equivalents declared (13,098) (13,098)       (13,098)    
Ending balance (in shares) at Sep. 30, 2023     76,806          
Ending balance at Sep. 30, 2023 966,646 928,366 $ 77 970,646 (122,770) 657,793 (577,380) 38,280
Changes in stockholders' equity                
Dividends and dividend equivalents declared (12,941)              
Ending balance (in shares) at Dec. 31, 2023     63,429          
Ending balance at Dec. 31, 2023 903,087 864,235 $ 63 808,615 (104,349) 159,906 0 38,852
Changes in stockholders' equity                
Net income (loss) 211,265 215,414       215,414   (4,149)
Other comprehensive loss (income) (3,750) (3,750)     (3,750)      
Share-based compensation 23,522 23,522   23,522        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     442          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (16,600) (16,600)   (16,600)        
Purchases of common stock (Note 10) (in shares)     (2,215)          
Purchases of common stock (Note 10) (143,584) (143,584) $ (1) (28,289)   (115,294)    
Share repurchase liability (Note 10) (32,523) (32,523)         (32,523)  
Dividends and dividend equivalents declared (41,815) (41,815)       (41,815)    
Redemption value adjustment (Note 1) (1,000) (1,000)       (1,000)    
Ending balance (in shares) at Sep. 30, 2024     61,656          
Ending balance at Sep. 30, 2024 898,602 863,899 $ 62 787,248 (108,099) 217,211 (32,523) 34,703
Beginning balance (in shares) at Jun. 30, 2024     62,729          
Beginning balance at Jun. 30, 2024 898,709 863,693 $ 63 792,559 (123,038) 231,608 (37,499) 35,016
Changes in stockholders' equity                
Net income (loss) 55,911 56,224       56,224   (313)
Other comprehensive loss (income) 14,939 14,939     14,939      
Share-based compensation 8,883 8,883   8,883        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     7          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (246) (246)   (246)        
Purchases of common stock (Note 10) (in shares)     (1,080)          
Purchases of common stock (Note 10) (70,783) (70,783) $ (1) (13,948)   (56,834)    
Share repurchase liability (Note 10) 4,976 4,976         4,976  
Dividends and dividend equivalents declared (13,787) (13,787)       (13,787)    
Ending balance (in shares) at Sep. 30, 2024     61,656          
Ending balance at Sep. 30, 2024 $ 898,602 $ 863,899 $ 62 $ 787,248 $ (108,099) $ 217,211 $ (32,523) $ 34,703